Gene Expression Analysis

Gene Expression Analysis

Global Gene Expression Analysis Market to Reach US$8.9 Billion by 2030

The global market for Gene Expression Analysis estimated at US$5.1 Billion in the year 2023, is expected to reach US$8.9 Billion by 2030, growing at a CAGR of 8.3% over the analysis period 2023-2030. Instruments Component, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$3.9 Billion by the end of the analysis period. Growth in the Consumables Component segment is estimated at 9.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.3 Billion While China is Forecast to Grow at 12.2% CAGR

The Gene Expression Analysis market in the U.S. is estimated at US$1.3 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2030 trailing a CAGR of 12.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.4% and 7.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR.

Global Gene Expression Analysis Market – Definition, Key Trends & Drivers Summarized

What Is Gene Expression Analysis and Why Is It Important in Modern Biotechnology?

Gene expression analysis refers to the process of studying how genes are transcribed into mRNA and how these mRNA molecules are translated into functional proteins. But why is this analysis critical in modern biotechnology and healthcare? Gene expression analysis provides insights into the function of genes under different conditions, helping researchers understand the role of specific genes in health and disease. It is widely used in various fields such as cancer research, drug development, diagnostics, and personalized medicine. By examining how gene expression patterns change in response to disease, treatments, or environmental factors, scientists can identify disease biomarkers, potential therapeutic targets, and monitor the effects of drugs at the molecular level. This makes gene expression analysis a powerful tool in identifying and understanding the mechanisms of diseases like cancer, autoimmune disorders, and genetic conditions. With the rise of precision medicine, gene expression analysis is becoming even more integral to tailoring treatments based on individual genetic profiles, improving patient outcomes.

How Are Technological Advancements Shaping the Gene Expression Analysis Market?

Technological advancements in molecular biology and genomics are driving the evolution of gene expression analysis. But how are these innovations improving the accuracy and efficiency of gene expression studies? One of the most significant trends is the development of next-generation sequencing (NGS) technologies, which allow for high-throughput analysis of gene expression across the entire genome. NGS provides researchers with an in-depth understanding of transcriptomics, enabling them to study how different genes are expressed in specific tissues, under certain conditions, or during disease progression. This technology has dramatically reduced the cost and time required for gene expression analysis, allowing for more comprehensive studies at a larger scale. Another key innovation is real-time PCR (qPCR), which is widely used for quantifying gene expression levels. qPCR offers high sensitivity, accuracy, and specificity, making it the gold standard for validating gene expression results from high-throughput platforms like NGS. Additionally, advancements in microarray technology continue to play a role in gene expression profiling, particularly in diagnostics and biomarker discovery. Furthermore, the integration of bioinformatics and AI into gene expression analysis is transforming the way researchers interpret complex data. AI-driven algorithms can analyze large gene expression datasets, identify patterns, and predict disease outcomes or treatment responses with greater accuracy. The ability to combine vast amounts of genetic data with clinical information is enhancing our understanding of gene regulation and enabling more targeted therapeutic approaches. These technological advancements are making gene expression analysis faster, more accurate, and scalable, leading to its wider application in research and clinical settings.

How Are Healthcare and Research Trends Impacting the Gene Expression Analysis Market?

What role do healthcare and research trends play in shaping the gene expression analysis market? The growing focus on personalized medicine is one of the main drivers of gene expression analysis, as researchers and clinicians increasingly aim to tailor treatments based on a patient’s genetic profile. Gene expression studies provide insights into how individual genetic differences influence responses to drugs, enabling more personalized and effective treatment plans. This is particularly important in fields like oncology, where understanding the gene expression patterns of tumors can guide the selection of targeted therapies, improving patient outcomes.

Another trend influencing the market is the increased demand for biomarker discovery. Gene expression analysis helps identify biomarkers associated with specific diseases, which can be used for early detection, diagnosis, and monitoring of disease progression. For example, in cancer research, gene expression signatures are being used to stratify patients and predict their response to specific treatments. This ability to identify biomarkers through gene expression profiling is also advancing the field of companion diagnostics, where tests are developed to accompany therapies and help clinicians determine the most appropriate treatment for individual patients. Additionally, the rise of disease genomics and transcriptomics is fueling the demand for gene expression analysis in academic and pharmaceutical research. Researchers are using gene expression analysis to study the underlying genetic mechanisms of various diseases, develop new drugs, and assess the efficacy and safety of treatments. These research trends, combined with advancements in technology, are pushing the boundaries of how gene expression analysis is applied, making it a critical tool in both clinical and research settings.

What Are the Key Drivers Behind the Growth of the Gene Expression Analysis Market?

The growth in the gene expression analysis market is driven by several key factors, including advancements in genomics technologies, increasing research activities in drug discovery and development, and the growing demand for personalized medicine. One of the primary drivers is the rapid evolution of next-generation sequencing (NGS), which allows for the high-throughput analysis of gene expression at unprecedented levels of detail. NGS has made it easier and more affordable for researchers to study gene expression patterns in a wide variety of biological contexts, from cancer and infectious diseases to aging and developmental biology. Another significant driver is the expansion of pharmaceutical and biotechnology research, where gene expression analysis is being used to discover novel drug targets, understand disease mechanisms, and optimize drug efficacy. Pharmaceutical companies are increasingly using gene expression data to develop and validate new therapies, particularly in complex diseases like cancer, autoimmune disorders, and neurological conditions. This has led to a growing demand for advanced gene expression tools and technologies in both preclinical and clinical research. The rising demand for precision medicine is also contributing to the market’s growth. As healthcare providers move toward more personalized treatment approaches, gene expression analysis is becoming a key component of diagnostic and therapeutic decision-making. By analyzing the gene expression profiles of individual patients, clinicians can tailor treatments based on the genetic makeup of tumors, drug metabolism, or immune responses, leading to better patient outcomes and reduced healthcare costs. Finally, the growing use of bioinformatics and artificial intelligence (AI) in analyzing gene expression data is enhancing the ability to extract meaningful insights from complex datasets. AI-driven platforms can process large-scale gene expression data and provide predictive insights into disease progression, treatment responses, and patient outcomes. These factors—technological advancements, increased research activities, and the shift toward personalized medicine—are driving the rapid growth of the gene expression analysis market, with significant potential for future innovation and expansion.

Select Competitors (Total 42 Featured) -
  • Agilent Technologies
  • Bgi
  • Bio-Rad Laboratories,Inc.
  • ELITechGroup
  • Eurofins Scientific
  • F. Hoffmann-La Roche
  • Ge Healthcare
  • Illumina,Inc.
  • Novogene Corporation
  • Oxford Gene Technology
  • Pacific Biosciences of California, Inc.
  • Perkinelmer, Inc.
  • Qiagen N.V.
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
Gene Expression Analysis – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Demand for Personalized Medicine Drives Growth in Gene Expression Analysis for Tailored Therapeutic Solutions
Technological Advancements in Next-Generation Sequencing (NGS) Propel Growth in High-Throughput Gene Expression Profiling
Increasing Focus on Cancer Research Expands Market for Gene Expression Analysis in Tumor Profiling and Biomarker Discovery
Growing Adoption of Gene Expression Analysis in Drug Development Supports Market for Identifying Drug Targets and Monitoring Efficacy
Technological Innovations in Real-Time PCR (qPCR) Drive Growth in Accurate and Quantitative Gene Expression Measurement
Rising Use of Gene Expression Data in Diagnostics Expands Opportunities for Early Disease Detection and Personalized Treatments
Increasing Demand for Gene Expression Analysis in Agricultural Biotechnology Fuels Growth in Crop Improvement and Trait Selection
Technological Advancements in Bioinformatics Propel Growth in Data Analytics Tools for Gene Expression Analysis
Rising Prevalence of Chronic Diseases, Including Diabetes and Cardiovascular Diseases, Expands Market for Gene Expression Studies in Disease Mechanisms
Growing Interest in Epigenetics and Gene-Environment Interactions Drives Demand for Gene Expression Analysis in Epigenomic Research
Increasing Adoption of Single-Cell Gene Expression Analysis Strengthens Market for High-Resolution Cellular Studies
Rising Use of Gene Expression Profiling in Neurological Research Expands Market for Understanding Neurodegenerative Diseases
Growing Focus on Immune Response Studies Propels Demand for Gene Expression Analysis in Immunotherapy Research
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Gene Expression Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Gene Expression Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Gene Expression Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 15: World 16-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Academic Institutes & Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 17: World Historic Review for Academic Institutes & Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 18: World 16-Year Perspective for Academic Institutes & Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 20: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 21: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 22: World Gene Expression Analysis Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
Gene Expression Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 23: USA Recent Past, Current & Future Analysis for Gene Expression Analysis by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 24: USA Historic Review for Gene Expression Analysis by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 25: USA 16-Year Perspective for Gene Expression Analysis by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
TABLE 26: USA Recent Past, Current & Future Analysis for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 27: USA Historic Review for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 28: USA 16-Year Perspective for Gene Expression Analysis by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
CANADA
TABLE 29: Canada Recent Past, Current & Future Analysis for Gene Expression Analysis by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 30: Canada Historic Review for Gene Expression Analysis by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 31: Canada 16-Year Perspective for Gene Expression Analysis by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
TABLE 32: Canada Recent Past, Current & Future Analysis for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 33: Canada Historic Review for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 34: Canada 16-Year Perspective for Gene Expression Analysis by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
JAPAN
Gene Expression Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 35: Japan Recent Past, Current & Future Analysis for Gene Expression Analysis by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 36: Japan Historic Review for Gene Expression Analysis by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: Japan 16-Year Perspective for Gene Expression Analysis by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
TABLE 38: Japan Recent Past, Current & Future Analysis for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: Japan Historic Review for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: Japan 16-Year Perspective for Gene Expression Analysis by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
CHINA
Gene Expression Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 41: China Recent Past, Current & Future Analysis for Gene Expression Analysis by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: China Historic Review for Gene Expression Analysis by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: China 16-Year Perspective for Gene Expression Analysis by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
TABLE 44: China Recent Past, Current & Future Analysis for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: China Historic Review for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: China 16-Year Perspective for Gene Expression Analysis by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
EUROPE
Gene Expression Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 47: Europe Recent Past, Current & Future Analysis for Gene Expression Analysis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 48: Europe Historic Review for Gene Expression Analysis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: Europe 16-Year Perspective for Gene Expression Analysis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 50: Europe Recent Past, Current & Future Analysis for Gene Expression Analysis by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: Europe Historic Review for Gene Expression Analysis by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: Europe 16-Year Perspective for Gene Expression Analysis by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
TABLE 53: Europe Recent Past, Current & Future Analysis for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: Europe Historic Review for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: Europe 16-Year Perspective for Gene Expression Analysis by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
FRANCE
Gene Expression Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 56: France Recent Past, Current & Future Analysis for Gene Expression Analysis by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: France Historic Review for Gene Expression Analysis by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: France 16-Year Perspective for Gene Expression Analysis by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
TABLE 59: France Recent Past, Current & Future Analysis for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: France Historic Review for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: France 16-Year Perspective for Gene Expression Analysis by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
GERMANY
Gene Expression Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 62: Germany Recent Past, Current & Future Analysis for Gene Expression Analysis by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: Germany Historic Review for Gene Expression Analysis by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: Germany 16-Year Perspective for Gene Expression Analysis by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
TABLE 65: Germany Recent Past, Current & Future Analysis for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 66: Germany Historic Review for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: Germany 16-Year Perspective for Gene Expression Analysis by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
ITALY
TABLE 68: Italy Recent Past, Current & Future Analysis for Gene Expression Analysis by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: Italy Historic Review for Gene Expression Analysis by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: Italy 16-Year Perspective for Gene Expression Analysis by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
TABLE 71: Italy Recent Past, Current & Future Analysis for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 72: Italy Historic Review for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: Italy 16-Year Perspective for Gene Expression Analysis by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
UNITED KINGDOM
Gene Expression Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 74: UK Recent Past, Current & Future Analysis for Gene Expression Analysis by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: UK Historic Review for Gene Expression Analysis by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: UK 16-Year Perspective for Gene Expression Analysis by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
TABLE 77: UK Recent Past, Current & Future Analysis for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: UK Historic Review for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: UK 16-Year Perspective for Gene Expression Analysis by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
SPAIN
TABLE 80: Spain Recent Past, Current & Future Analysis for Gene Expression Analysis by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: Spain Historic Review for Gene Expression Analysis by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: Spain 16-Year Perspective for Gene Expression Analysis by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
TABLE 83: Spain Recent Past, Current & Future Analysis for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: Spain Historic Review for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: Spain 16-Year Perspective for Gene Expression Analysis by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
RUSSIA
TABLE 86: Russia Recent Past, Current & Future Analysis for Gene Expression Analysis by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: Russia Historic Review for Gene Expression Analysis by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: Russia 16-Year Perspective for Gene Expression Analysis by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
TABLE 89: Russia Recent Past, Current & Future Analysis for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: Russia Historic Review for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: Russia 16-Year Perspective for Gene Expression Analysis by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Gene Expression Analysis by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: Rest of Europe Historic Review for Gene Expression Analysis by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: Rest of Europe 16-Year Perspective for Gene Expression Analysis by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Rest of Europe Historic Review for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Rest of Europe 16-Year Perspective for Gene Expression Analysis by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Gene Expression Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Gene Expression Analysis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 99: Asia-Pacific Historic Review for Gene Expression Analysis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Asia-Pacific 16-Year Perspective for Gene Expression Analysis by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Gene Expression Analysis by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: Asia-Pacific Historic Review for Gene Expression Analysis by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Asia-Pacific 16-Year Perspective for Gene Expression Analysis by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: Asia-Pacific Historic Review for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: Asia-Pacific 16-Year Perspective for Gene Expression Analysis by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
AUSTRALIA
Gene Expression Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 107: Australia Recent Past, Current & Future Analysis for Gene Expression Analysis by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: Australia Historic Review for Gene Expression Analysis by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: Australia 16-Year Perspective for Gene Expression Analysis by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
TABLE 110: Australia Recent Past, Current & Future Analysis for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 111: Australia Historic Review for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 112: Australia 16-Year Perspective for Gene Expression Analysis by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
INDIA
Gene Expression Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 113: India Recent Past, Current & Future Analysis for Gene Expression Analysis by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 114: India Historic Review for Gene Expression Analysis by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 115: India 16-Year Perspective for Gene Expression Analysis by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
TABLE 116: India Recent Past, Current & Future Analysis for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 117: India Historic Review for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 118: India 16-Year Perspective for Gene Expression Analysis by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 119: South Korea Recent Past, Current & Future Analysis for Gene Expression Analysis by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 120: South Korea Historic Review for Gene Expression Analysis by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 121: South Korea 16-Year Perspective for Gene Expression Analysis by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
TABLE 122: South Korea Recent Past, Current & Future Analysis for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 123: South Korea Historic Review for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 124: South Korea 16-Year Perspective for Gene Expression Analysis by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gene Expression Analysis by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 126: Rest of Asia-Pacific Historic Review for Gene Expression Analysis by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Gene Expression Analysis by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 129: Rest of Asia-Pacific Historic Review for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Gene Expression Analysis by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
LATIN AMERICA
Gene Expression Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 131: Latin America Recent Past, Current & Future Analysis for Gene Expression Analysis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 132: Latin America Historic Review for Gene Expression Analysis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 133: Latin America 16-Year Perspective for Gene Expression Analysis by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 134: Latin America Recent Past, Current & Future Analysis for Gene Expression Analysis by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 135: Latin America Historic Review for Gene Expression Analysis by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 136: Latin America 16-Year Perspective for Gene Expression Analysis by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
TABLE 137: Latin America Recent Past, Current & Future Analysis for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 138: Latin America Historic Review for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 139: Latin America 16-Year Perspective for Gene Expression Analysis by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 140: Argentina Recent Past, Current & Future Analysis for Gene Expression Analysis by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 141: Argentina Historic Review for Gene Expression Analysis by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 142: Argentina 16-Year Perspective for Gene Expression Analysis by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
TABLE 143: Argentina Recent Past, Current & Future Analysis for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 144: Argentina Historic Review for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 145: Argentina 16-Year Perspective for Gene Expression Analysis by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
BRAZIL
TABLE 146: Brazil Recent Past, Current & Future Analysis for Gene Expression Analysis by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 147: Brazil Historic Review for Gene Expression Analysis by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 148: Brazil 16-Year Perspective for Gene Expression Analysis by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
TABLE 149: Brazil Recent Past, Current & Future Analysis for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 150: Brazil Historic Review for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 151: Brazil 16-Year Perspective for Gene Expression Analysis by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
MEXICO
TABLE 152: Mexico Recent Past, Current & Future Analysis for Gene Expression Analysis by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 153: Mexico Historic Review for Gene Expression Analysis by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 154: Mexico 16-Year Perspective for Gene Expression Analysis by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
TABLE 155: Mexico Recent Past, Current & Future Analysis for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 156: Mexico Historic Review for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 157: Mexico 16-Year Perspective for Gene Expression Analysis by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Gene Expression Analysis by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 159: Rest of Latin America Historic Review for Gene Expression Analysis by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 160: Rest of Latin America 16-Year Perspective for Gene Expression Analysis by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 162: Rest of Latin America Historic Review for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 163: Rest of Latin America 16-Year Perspective for Gene Expression Analysis by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
MIDDLE EAST
Gene Expression Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 164: Middle East Recent Past, Current & Future Analysis for Gene Expression Analysis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 165: Middle East Historic Review for Gene Expression Analysis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 166: Middle East 16-Year Perspective for Gene Expression Analysis by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 167: Middle East Recent Past, Current & Future Analysis for Gene Expression Analysis by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 168: Middle East Historic Review for Gene Expression Analysis by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 169: Middle East 16-Year Perspective for Gene Expression Analysis by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
TABLE 170: Middle East Recent Past, Current & Future Analysis for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 171: Middle East Historic Review for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 172: Middle East 16-Year Perspective for Gene Expression Analysis by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
IRAN
TABLE 173: Iran Recent Past, Current & Future Analysis for Gene Expression Analysis by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 174: Iran Historic Review for Gene Expression Analysis by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 175: Iran 16-Year Perspective for Gene Expression Analysis by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
TABLE 176: Iran Recent Past, Current & Future Analysis for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 177: Iran Historic Review for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 178: Iran 16-Year Perspective for Gene Expression Analysis by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
ISRAEL
TABLE 179: Israel Recent Past, Current & Future Analysis for Gene Expression Analysis by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 180: Israel Historic Review for Gene Expression Analysis by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 181: Israel 16-Year Perspective for Gene Expression Analysis by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
TABLE 182: Israel Recent Past, Current & Future Analysis for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 183: Israel Historic Review for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 184: Israel 16-Year Perspective for Gene Expression Analysis by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Gene Expression Analysis by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 186: Saudi Arabia Historic Review for Gene Expression Analysis by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 187: Saudi Arabia 16-Year Perspective for Gene Expression Analysis by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 189: Saudi Arabia Historic Review for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 190: Saudi Arabia 16-Year Perspective for Gene Expression Analysis by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 191: UAE Recent Past, Current & Future Analysis for Gene Expression Analysis by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 192: UAE Historic Review for Gene Expression Analysis by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 193: UAE 16-Year Perspective for Gene Expression Analysis by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
TABLE 194: UAE Recent Past, Current & Future Analysis for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 195: UAE Historic Review for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 196: UAE 16-Year Perspective for Gene Expression Analysis by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Gene Expression Analysis by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 198: Rest of Middle East Historic Review for Gene Expression Analysis by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 199: Rest of Middle East 16-Year Perspective for Gene Expression Analysis by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 201: Rest of Middle East Historic Review for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 202: Rest of Middle East 16-Year Perspective for Gene Expression Analysis by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
AFRICA
Gene Expression Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 203: Africa Recent Past, Current & Future Analysis for Gene Expression Analysis by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 204: Africa Historic Review for Gene Expression Analysis by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 205: Africa 16-Year Perspective for Gene Expression Analysis by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
TABLE 206: Africa Recent Past, Current & Future Analysis for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 207: Africa Historic Review for Gene Expression Analysis by End-Use - Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 208: Africa 16-Year Perspective for Gene Expression Analysis by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Institutes & Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings